Pulse Biosciences (PLSE) Invested Capital (2021 - 2023)

Pulse Biosciences has reported Invested Capital for 3 years, with the latest figure at $44.4 million in Q4 2023.

• On a quarterly basis, Invested Capital fell 30.33% year-over-year to $44.4 million in Q4 2023; TTM through Dec 2023 was $44.4 million, a 30.33% decrease from a year earlier, with the FY2023 full-year figure at $44.4 million, down 30.33% from the prior year.
• Invested Capital was $44.4 million for Q4 2023 at Pulse Biosciences, down from $52.1 million in the prior quarter.
• The five-year high for Invested Capital was $71.3 million in Q3 2022, with the low at $44.4 million in Q4 2023.
• Average Invested Capital over 3 years is $56.3 million, with a median of $57.8 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Invested Capital surged 47.07% in 2022, then slumped 30.33% in 2023.
• Over 3 years, Invested Capital stood at $44.8 million in 2021, then surged by 42.13% to $63.7 million in 2022, then plunged by 30.33% to $44.4 million in 2023.
• The last three Invested Capital figures came in at $44.4 million (Q4 2023), $52.1 million (Q3 2023), and $60.5 million (Q2 2023), per Business Quant data.